5-HYDROXYINDOLE COMPOUNDS IN THE CEREBROSPINAL FLUID OF PATIENTS WITH PSYCHIATRIC OR NEUROLOGICAL DISEASES
- 1 November 1966
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 288 (7472), 1049-1052
- https://doi.org/10.1016/s0140-6736(66)92028-9
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecidLife Sciences, 1966
- Tryptamine Metabolism in DepressionThe British Journal of Psychiatry, 1965
- Changes in amine metabolism produced by antidepressant drugsJournal of Psychosomatic Research, 1965
- EFFECT OF MONOAMINE-OXIDASE INHIBITORS ON THE CONCENTRATIONS OF 5-HYDROXYTRYPTAMINE IN THE HUMAN BRAINThe Lancet, 1965
- Studies on sodium transfer and 5-hydroxyindoles in depressive illnessJournal of Neurology, Neurosurgery & Psychiatry, 1963
- The effect of monoamine oxidase inhibitors on the level of 5-hydroxyindoleacetic acid in human cerebrospinal fluidLife Sciences, 1963
- Isolation and Characterization of a Compound from the Urine of SchizophrenicsNature, 1962
- Body Fluid Indoles in Mental IllnessInternational Review of Neurobiology, 1961
- 5-Hydroxyindoles in Human Cerebrospinal FluidsNature, 1960
- A SIMPLIFIED METHOD FOR MEASURING SEROTONIN IN TISSUES; SIMULTANEOUS ASSAY OF BOTH SEROTONIN AND HISTAMINEJournal of Biological Chemistry, 1958